In this second segment of Bob Proulx’s presentation to investors at the 2016 NobleCon meeting, he answers the question of how magnetic relaxometry might be used in cancer medicine. This video introduces roles for magnetic relaxometry in early cancer detection, cancer staging, and therapeutic monitoring. It also outlines the unique capabilities of magnetic relaxometry relative to MRI, ultrasound, X-ray imaging, blood biomarkers, and biopsies.
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal